These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 5039460)

  • 1. A comparison of factor VIII activity in cryoprecipitates prepared from ACD and CPD plasma.
    Shanberge JN; Gruhl MC; Ikemori R; Inoshita K; Chalos MK; Aster RH
    Transfusion; 1972; 12(4):251-8. PubMed ID: 5039460
    [No Abstract]   [Full Text] [Related]  

  • 2. Clotting factor activity in cryoprecipitates and supernatant plasma prepared from blood collected into ACD, ACD-adenine, CPD, and CPD-adenine and from plasma collected by plasmapheresis.
    Graybeal FQ; Mooreside DE; Langdell RD
    Transfusion; 1969; 9(3):135-40. PubMed ID: 5782206
    [No Abstract]   [Full Text] [Related]  

  • 3. Preservation of coagulation factors V and VIII during collection and subsequent storage of bank blood in ACD-A and CPD solutions.
    Weisert O; Jeremic M
    Vox Sang; 1973 Feb; 24(2):126-33. PubMed ID: 4682805
    [No Abstract]   [Full Text] [Related]  

  • 4. Improved yields of factor VIII from heparinized plasma.
    Rock GA; Cruickshank WH; Tackaberry ES; Palmer DS
    Vox Sang; 1979; 36(5):294-300. PubMed ID: 462918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of the primary anticoagulant on the recovery of factor VIII in cryoprecipitate.
    de Wit HJ; Scheer G; Muradin J; van der Does JA
    Vox Sang; 1986; 51(3):172-5. PubMed ID: 3101286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of plasma with high levels of ionised calcium in the production of model scale coagulation factor concentrates.
    Farrugia A; Douglas S; James J; Whyte G; Herrington R
    Thromb Haemost; 1990 Nov; 64(3):374-8. PubMed ID: 2128967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of ACD and CPD anticoagulants on white cell aggregation.
    Lycette RM
    Transfusion; 1973; 13(6):435-8. PubMed ID: 4749647
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative viability of blood stored in ACD and CPD.
    Orlina AR; Josephson AM
    Transfusion; 1969; 9(2):62-9. PubMed ID: 5767405
    [No Abstract]   [Full Text] [Related]  

  • 9. Preparation of improved cryoprecipitated factor VIII concentrate. A controlled study of three variables affecting the yield.
    Wensley RT; Snape TJ
    Vox Sang; 1980; 38(4):222-8. PubMed ID: 6774480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of coagulation factors I and X during collection and subsequent storage of bank blood in ACD-A and CPD solutions.
    Weisert O; Jeremic M
    Vox Sang; 1973 Apr; 24(4):377-9. PubMed ID: 4691235
    [No Abstract]   [Full Text] [Related]  

  • 11. Development of plasma derivatives for clinical use.
    Tullis JL
    Vox Sang; 1972; 23(1):3-9. PubMed ID: 4117048
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of plasma freezing temperature, anticoagulant and time of storage on factor VIII:C activity in cryoprecipitate.
    Piedras J; Sánchez-Montero PE; Herrera FM; Córdova MS; Sánchez-Medal L
    Arch Med Res; 1993; 24(1):23-6. PubMed ID: 8292873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the procurement of blood coagulation factor VIII. In vivo studies on blood components prepared in half-strength citrate anticoagulant.
    Griffin B; Bell K; Prowse C
    Vox Sang; 1988; 54(4):193-8. PubMed ID: 3133879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of citrate anticoagulants on factor VIII levels in plasma.
    Rock G; Tittley P; Fuller V
    Transfusion; 1988; 28(3):248-52. PubMed ID: 3130694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased yield of F VIII from pooled plasma vs. single-donor plasma in the production of cryoprecipitates.
    Rácz Z; Thék M; Jánossy A; Pintér J; Baróti C
    Arch Med Res; 1997; 28(2):179-82. PubMed ID: 9204605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole blood storage in citrate and phosphate solutions containing half-strength trisodium citrate: cellular and biochemical studies.
    Mishler JM; Darley JH; Cederholm-Williams S; Wright G
    J Pathol; 1978 Mar; 124(3):125-39. PubMed ID: 722376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The preparation and use of cryoprecipitates].
    Roewer J; Wilms K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 91(4):496-506. PubMed ID: 4184476
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of the primary anticoagulant on the recovery of factor VIII.
    Rock G
    Vox Sang; 1988; 54(2):125-6. PubMed ID: 3131962
    [No Abstract]   [Full Text] [Related]  

  • 19. The in vitro evaluation of modifications in CPD-adenine anticoagulated-preserved blood at various hematocrits.
    Moore GL; Ledford ME; Peck CC
    Transfusion; 1980; 20(4):419-26. PubMed ID: 7404640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The post-thaw viability of red blood cells of ACD and CPD blood preserved in the frozen state with and without added adenine.
    Gibson JG; Tullis JL; Tinch RJ; Ryan WR; DiForte S
    Transfusion; 1972; 12(3):198-207. PubMed ID: 5026173
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.